Stifel Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $135M | Buy |
684,404
+39,976
| +6% | +$7.71M | 0.12% | 187 |
|
|
2025
Q4 | $118M | Buy |
644,428
+56,046
| +10% | +$9.83M | 0.11% | 193 |
|
|
2025
Q3 | $90.3M | Buy |
588,382
+14,455
| +3% | +$2.19M | 0.08% | 242 |
|
|
2025
Q2 | $80.2M | Sell |
573,927
-25,343
| -4% | -$3.55M | 0.08% | 256 |
|
|
2025
Q1 | $88.1M | Sell |
599,270
-25,446
| -4% | -$3.68M | 0.09% | 228 |
|
|
2024
Q4 | $81.9M | Sell |
624,716
-49,736
| -7% | -$6.96M | 0.09% | 229 |
|
|
2024
Q3 | $105M | Buy |
674,452
+41,743
| +7% | +$6.74M | 0.11% | 190 |
|
|
2024
Q2 | $98.7M | Buy |
632,709
+69,353
| +12% | +$10.4M | 0.11% | 183 |
|
|
2024
Q1 | $76.3M | Sell |
563,356
-75,794
| -12% | -$10M | 0.09% | 229 |
|
|
2023
Q4 | $86.1M | Sell |
639,150
-39,044
| -6% | -$5.08M | 0.11% | 192 |
|
|
2023
Q3 | $91.9M | Buy |
678,194
+5,371
| +0.8% | +$734K | 0.13% | 181 |
|
|
2023
Q2 | $96.3M | Sell |
672,823
-10,381
| -2% | -$1.53M | 0.13% | 172 |
|
|
2023
Q1 | $94.8M | Buy |
683,204
+86,706
| +15% | +$11.7M | 0.14% | 165 |
|
|
2022
Q4 | $80.9M | Buy |
596,498
+15,038
| +3% | +$1.89M | 0.12% | 185 |
|
|
2022
Q3 | $63.8M | Buy |
581,460
+115,054
| +25% | +$14.6M | 0.1% | 202 |
|
|
2022
Q2 | $61.6M | Buy |
466,406
+289,236
| +163% | +$38M | 0.1% | 217 |
|
|
2022
Q1 | $23.5M | Sell |
177,170
-1,845
| -1% | -$221K | 0.03% | 458 |
|
|
2021
Q4 | $20.9M | Buy |
179,015
+1,801
| +1% | +$212K | 0.03% | 494 |
|
|
2021
Q3 | $21.3M | Buy |
177,214
+20,565
| +13% | +$2.39M | 0.03% | 460 |
|
|
2021
Q2 | $18.8M | Buy |
156,649
+5,572
| +4% | +$611K | 0.03% | 486 |
|
|
2021
Q1 | $15M | Sell |
151,077
-20,321
| -12% | -$2.04M | 0.02% | 518 |
|
|
2020
Q4 | $17.1M | Sell |
171,398
-273,431
| -61% | -$29M | 0.03% | 438 |
|
|
2020
Q3 | $48.8M | Buy |
444,829
+5,398
| +1% | +$600K | 0.1% | 197 |
|
|
2020
Q2 | $46.5M | Buy |
439,431
+243,352
| +124% | +$25.1M | 0.11% | 191 |
|
|
2020
Q1 | $17.5M | Buy |
196,079
+1,851
| +1% | +$174K | 0.05% | 312 |
|
|
2019
Q4 | $19.4M | Buy |
194,228
+45,595
| +31% | +$4.29M | 0.04% | 369 |
|
|
2019
Q3 | $13.2M | Sell |
148,633
-17,720
| -11% | -$1.54M | 0.03% | 455 |
|
|
2019
Q2 | $13.7M | Buy |
166,353
+49,697
| +43% | +$3.9M | 0.04% | 456 |
|
|
2019
Q1 | $9.43M | Sell |
116,656
-64,611
| -36% | -$5.09M | 0.03% | 558 |
|
|
2018
Q4 | $13.8M | Sell |
181,267
-11,517
| -6% | -$899K | 0.04% | 380 |
|
|
2018
Q3 | $15.3M | Sell |
192,784
-18,261
| -9% | -$1.38M | 0.04% | 375 |
|
|
2018
Q2 | $14.8M | Sell |
211,045
-21,777
| -9% | -$1.57M | 0.05% | 396 |
|
|
2018
Q1 | $16.3M | Buy |
232,822
+6,612
| +3% | +$458K | 0.05% | 366 |
|
|
2017
Q4 | $15.7M | Buy |
226,210
+23,300
| +11% | +$1.57M | 0.05% | 370 |
|
|
2017
Q3 | $13.8M | Buy |
202,910
+14,681
| +8% | +$927K | 0.05% | 388 |
|
|
2017
Q2 | $12.8M | Buy |
188,229
+8,005
| +4% | +$523K | 0.05% | 393 |
|
|
2017
Q1 | $11.2M | Buy |
180,224
+62,547
| +53% | +$3.64M | 0.04% | 418 |
|
|
2016
Q4 | $6.42M | Sell |
117,677
-37,876
| -24% | -$2.15M | 0.03% | 569 |
|
|
2016
Q3 | $10.3M | Buy |
155,553
+65,861
| +73% | +$4.31M | 0.05% | 370 |
|
|
2016
Q2 | $5.42M | Buy |
89,692
+6,301
| +8% | +$366K | 0.03% | 571 |
|
|
2016
Q1 | $4.7M | Buy |
83,391
+3,727
| +5% | +$224K | 0.03% | 561 |
|
|
2015
Q4 | $5.41M | Buy |
79,664
+11,551
| +17% | +$757K | 0.03% | 530 |
|
|
2015
Q3 | $4.33M | Sell |
68,113
-107,550
| -61% | -$7.08M | 0.02% | 571 |
|
|
2015
Q2 | $7.14M | Buy |
175,663
+75,067
| +75% | +$5.14M | 0.04% | 448 |
|
|
2015
Q1 | $6.88M | Sell |
100,596
-18,628
| -16% | -$1.29M | 0.04% | 507 |
|
|
2014
Q4 | $8.39M | Buy |
119,224
+2,454
| +2% | +$176K | 0.05% | 446 |
|
|
2014
Q3 | $8.34M | Buy |
116,770
+23,628
| +25% | +$1.73M | 0.07% | 321 |
|
|
2014
Q2 | $6.92M | Sell |
93,142
-25,961
| -22% | -$1.88M | 0.06% | 372 |
|
|
2014
Q1 | $7.73M | Buy |
+119,103
| New | +$7.69M | 0.07% | 327 |
|
Other funds holding AZN
IA
VCM
VAM
Stifel Financial's AZN Position: Q1 2026 in Review
Stifel Financial increased its AstraZeneca (AZN) stake by 6.2% in Q1 2026, buying an estimated $7.71M and bringing the position to 684,404 shares worth $135M. The position accounts for 0.12% of the portfolio, ranked #187.
Stifel Financial first reported a position in AZN in Q1 2014 and has held it in 49 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Stifel Financial held 684,404 shares of AstraZeneca worth $135M as of Q1 2026.
- Stifel Financial bought 39,976 AstraZeneca shares in Q1 2026, an estimated $7.71M.
- AstraZeneca made up 0.12% of Stifel Financial's portfolio in Q1 2026, its #187 holding.
- Stifel Financial first reported a position in AstraZeneca in Q1 2014 and has held it in 49 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.